Brief: Alimera Sciences Reports Fourth Quarter And FY 2021 Results
24/02/2022 13:28
Feb 24 (Reuters) - Alimera Sciences Inc ALIM.O :
* ALIMERA SCIENCES REPORTS FOURTH QUARTER AND FY 2021
RESULTS
* Q4 REVENUE ROSE 1 PERCENT TO $14 MILLION
* Q4 LOSS PER SHARE $0.59
Source text for Eikon: ID:nGNX2S3Lvy
Further company coverage: ALIM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger